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Protective ventilation with low tidal volume has been shown to reduce morbidity and mortality in patients suﬀering from acute
lung injury (ALI) and acute respiratory distress syndrome (ARDS). Low tidal volume ventilation is associated with particular
clinical challenges and is therefore often underutilized as a therapeutic option in clinical practice. Despite some potential
diﬃculties, data have been published examining the application of protective ventilation in patients without lung injury. We will
brieﬂy review the physiologic rationale for low tidal volume ventilation and explore the current evidence for protective ventilation
in patients without lung injury. In addition, we will explore some of the potential reasons for its underuse and provide strategies
to overcome some of the associated clinical challenges.
1.Introduction
Lung protective ventilation has evolved over the last several
decades and has focused largely on patients suﬀering from
acute respiratory distress syndrome (ARDS) and acute lung
injury(ALI).Thereisclearevidencefromanimalandhuman
data that mechanical ventilation can induce and exacerbate
lung injury, and thus the current standard of care is the use
of a lung protective ventilation strategy in patients suﬀering
from ALI/ARDS [1–3]. Protective ventilation refers to the
use of low tidal volume (VT), often in the range of 4–
8mL/kg of predicted body weight (PBW). In fact, 6mL/kg
is the normal physiologic VT in humans [4]. In ALI and in
ARDS, there is a breakdown of normal lung architecture,
loss of functioning lung units, and the development of
high-permeability pulmonary edema, all of which result in
clinicallystiﬀ,noncompliant,andheterogeneouslungs[5,6].
The ventilator in this setting can produce a wide array
of local and systemic adverse eﬀects, known as ventilator-
induced lung injury (VILI) [6, 7]. Mechanistically, these
pathophysiologicchangesoccurfromthedirecteﬀectofhigh
pressure on the lung, barotrauma, from the damage caused
by lung overdistension, volutrauma, from the shear stress of
repetitive opening and closing of alveoli, atelectotrauma,and
from the generation of cytokines and an inﬂammatory cas-
cade, resulting in biotrauma. This can perpetuate lung injury
as well as induce multiorgan failure, the most common cause
of death in patients with ARDS [8–10]. Many investigators
have conducted several large randomized trials that have
shown that the use of lower VTs is associated with improved
outcomes and a reduction in the incidence of VILI [11–15].
Indeed, over the last two decades, VTs in the intensive care
unit (ICU) have been reduced, predominantly in patients
with ALI or ARDS [16, 17]. However, evidence also exists
that mechanical ventilation can be injurious to the lungs and
other organ systems in patients without ALI or ARDS. We
will review the current literature concerning the use of pro-
tective ventilation in non-lung injured patients and highlight
important challenges that limit the successful implementa-
tion of protective ventilation in clinical practice.2 Critical Care Research and Practice
2. The History of ProtectiveVentilation
In 1963, a seminal paper by Bendixen in the New Eng-
land Journal of Medicine [18] demonstrated that the use
of higher VTs during anesthesia (18 patients undergoing
laparotomy) resulted in less atelectasis, less acidosis, and
improved oxygenation compared to lower VTs. Nearly ﬁfty
years later, anesthesiology textbooks continue to maintain
that VTs should be between 10–15mL/kg while undergoing
mechanical ventilation in order to avoid atelectasis and
hypoxia [19]. Following the original description of ARDS
by Ashbaugh et al. in 1967 [20], many studies have been
performed in ALI/ARDS patients with a variety of VTs
ranging from 10 to 24mL/kg [21–24]. It was not until the
1970sand1980sthatasigniﬁcantamountofdataﬁrststarted
to emerge focusing on the deleterious eﬀects of large VTs in
the lungs of animals [7, 25, 26] and it was Hickling who ﬁrst
proposed the notion of permissive hypercapnia with the use
of low VT [27, 28]. It was many years later when random-
ized clinical data emerged in humans revealing improved
outcomes with the use of lower VTs with or without the
use of high levels of positive end-expiratory pressure (PEEP),
although initial data was conﬂicting [11–14, 29–31]. Amato
et al. performed a randomized trial on 53 patients with
ARDS, which revealed a reduction in 28-day mortality from
71%to38%using12mL/kgversus6mL/kg[12].Inthesame
year,twootherclinicaltrialsemergedwithconﬂictingresults.
A trial by Brochard et al. compared VTs of <10mL/kg versus
≥10mL/kg in 116 patients with ARDS and failed to show a
signiﬁcant reduction in mortality (37.9% versus 46.6% P =
0.38), barotraumas, or multiorgan dysfunction [13]. Stewart
et al. completed a similar trial in 120 patients comparing
a VT of 8mL/kg versus 10–15mL/kg, which again did not
result in a reduction in mortality (50% versus 47%, resp.)
[14]. In 2006, Villar et al. randomized patients with ARDS to
receive a VT of 9–11mL/kg PBW with a PEEP ≥5cmH 2Oo r
to a VT of 5–8mL/kg PBW with a PEEP level setting based
on the lower inﬂection point of the pressure-volume curve.
They demonstrated an increase in ventilator free days and
importantly a reduction in both ICU and hospital mortality
[32].
In 2000, the largest and most inﬂuential trial was pub-
lished by the Acute Respiratory Distress Syndrome Network,
where they randomized 861 patients to a protective low VT
strategy of 6mL/kg of PBW with a plateau pressure less than
30cmH2O,versus12mL/kg withaplateaupressurelessthan
50cmH2O.Theyfoundastatisticallysigniﬁcantreductionin
mortality from 39.8% to 31% in the lower VT group [11].
Based on these results, current guidelines recommend VTs of
6mL/kg of PBW for the management of patients with ALI or
ARDS [33].
In addition to the reduction of tidal volume, increasing
the level of PEEP is now considered an integral part of
protective ventilation. The use of PEEP in ALI/ARDS and
in particular at what level and how to set PEEP has not
been without controversy. Coupled with a low tidal volume
strategy three large randomized controlled trials have been
published in the last decade: the ALVEOLI trial published
in 2004 and the LOVS and EXPRESS trials in 2008 [29–31].
A recent meta-analysis, examining the data from the 3 trials
which included 2299 individual patients, demonstrated that
higher levels of PEEP were associated with improved survival
among ARDS but not ALI patients [34].
The eﬀect of low VT ventilation with higher levels of
PEEP in patients without ALI or ARDS is less well known.
3. ProtectiveVentilationinPatients
without LungInjury
In addition to mechanical ventilation aggravating the course
of disease in patients already suﬀering from ALI/ARDS,
mechanical ventilation can also lead to the development of
ALI/ARDS [35]. Once the lung has been “primed” by an
initial physiologic insult such as pneumonia, aspiration, sep-
sis, blood transfusions or cardiopulmonary bypass, injurious
mechanical ventilation can then initiate a pulmonary and
systemic inﬂammatory response leading to ALI or ARDS
[35]. Consequently, ventilated patients at highest risk for
the development of further lung injury are those who are
critically ill and undergo high-risk surgeries or who have
an illness requiring an ICU admission (Tables 1 and 2).
These patients may therefore beneﬁt from a strategy of low
tidal volume ventilation to reduce the risk of developing
ALI/ARDS.
In 2004, Gajic et al. conducted a retrospective cohort
study of mixed medical-surgical patients receiving mechan-
ical ventilation for >48hrs in the ICU who did not have
ALI at the time of intubation [35]. This study analyzed 332
patients of which 80 (24%) developed ALI within 5 days
of mechanical ventilation. Women tended to have higher
VT (11.4 versus 10.4mL/kg PBW) and developed ALI more
frequently (29% versus 20%, P<0.068). A multivariate
analysisrevealedanincreasedriskofdevelopingALIwiththe
use of volumes greater than 6mL/kg PBW (OR 1.3 for every
1mL> 6mL/kg,P<0.001).
In another study by Gajic et al., analysis of a large in-
ternational database of over three thousand mechanically
ventilated medical-surgical ICU patients without ALI/ARDS
showed that ARDS developed in 6.2% of patients after 48hrs
of mechanical ventilation. Most patients were admitted with
sepsis, pneumonia, trauma or post-operatively. A multivari-
ate analysis revealed that the use of a VT greater than 700mL
wasassociatedwithanoddsratioof2.66forthedevelopment
of ARDS (P<0.001) [36].
Determann et al. recently performed a randomized non-
blinded two-centre trial comparing conventional 10mL/kg
PBW to 6mL/kg PBW in 152 critically ill medical/surgical
patients [37]. Patients were randomized within 36 hours of
initiation of mechanical ventilation. The primary outcome
was the measurement of cytokine levels in bronchoalve-
olar lavage (BAL) ﬂuid and plasma. Secondary outcomes
included the development of ALI/ARDS, duration of ven-
tilation, and overall mortality. Despite balanced baseline
demographics including known risk factors for ALI/ARDS,
the trial was stopped early when more patients developed
lung injury in the conventional group, 13.5% versus 2.6%
(P = 0.01). The relative risk for developing lung injury with
conventional ventilation was 5.1 (95% CI, 1.2–22.6). PlasmaCritical Care Research and Practice 3
Table 1: Impact of ventilation strategy after noncardiac and cardiac surgery.
Reference
(year)
Type of patients
(n) VT-PEEP Main results
mL/kg cmH2O
Non-cardiac surgery
Fern´ andez-P´ erez et
al. (2006) [42]
Observational
Pneumonectomy (170) VT 8.3 versus 6.7 18% postoperative ARF VT was a risk factor
for ARF
Michelet et al.
(2006) [43]R C T Esophagectomy (52) VT 9/9-PEEP 0
VT 9/5-PEEP 5
  inﬂammatory markers
  oxygenation,   MV duration
Lee et al. (1990)
[41]R C T Mixed postop patients (103) VT 12 versus 6 Trend for   pulmonary infections
and   MV duration
Wrigge et al.
(2000) [55]R C T Elective surgeries (39)
VT 15-PEEP 0
VT 6-PEEP 0
VT 6-PEEP 10
No diﬀerence in inﬂammatory markers 1h
after surgery
Wrigge et al.
(2004) [26]RCT
Abdominal and thoracic
surgeries (64)
VT 12–15-PEEP 0
VT 6-PEEP 10
No diﬀerence in inﬂammatory markers 3hrs
after surgery
Choi et al. (2006)
[56]R C T Prolonged surgeries (40) VT 12-PEEP 0
VT 6-PEEP 10
  coagulation activation after 5hrs of MV
Weingarten et al.
(2010) [44]R C T
Major abdominal surgeries
(40)
VT 10-PEEP 0
VT 6-PEEP 12
Improved respiratory mechanics and
oxygenation, no diﬀerence in biomarkers
Cardiac surgery
Koner et al. (2004)
[51]R C T CABG (44) VT 10-PEEP 0
VT 6-PEEP 5
No diﬀerence on inﬂammation
  oxygenation with PEEP
Wrigge et al.
(2005) [52]R C T CABG (44)
VT 6-PEEP 10
VT 12-PEEP 7
VT 6-PEEP 9
  TNF in BAL
Reis Miranda et al.
(2005) [50]R C T CABG (62) VT 6–8-PEEP 5
VT 4–6-PEEP 10 More rapid   in proinﬂammatory cytokines
Zupancich et al.
(2005) [49]R C T CABG (40) VT 10–12∗-PEEP 2-3
VT 8∗-PEEP 10
  proinﬂammatory cytokines after
cardiopulmonary bypass
Sundar et al.
(2011) [53]R C T CABG, Valves (149) VT 10-PEEP > 5
VT 6-PEEP > 5
Less intubated patients after 6 hrs
Less reintubation
Lellouche et al.
(2010) [54]
Observational
CABG, Valves (3434) VT < 10 versus 10–12
versus > 12
  organ dysfunction and   ICU length of
stay with high and traditional VT
RCT: randomized controlled studies. MV: mechanical ventilation. ARF: acute respiratory failure. BAL: bronchoalveolar lavage. TNF: tumour necrosis factor.
VT: tidal volume.
∗mL/Kg of actual body weight (ABW).
IL-6 levels decreased over 4 days and were more pronounced
in the low VT group (21ng/mL versus 11ng/mL, P = 0.01).
BAL cytokine levels including IL-6 tended to be higher in
the conventional group, although it was not statistically
signiﬁcant.
A multicenter randomized controlled trial by Mascia et
al. enrolled 118 potential organ donors with normal lungs,
who received either conventional or protective ventilation
[38]. Current guidelines for the management of organ
donors suggest 8–15mL/kg of VT [39, 40]. Patients receiving
conventional ventilation were treated with 10–12mL/kg
P B Ww i t haP E E Po f3 – 5 c m H 20 for six hours, whereas
patients receiving protective ventilation were treated with
6–8mL/kg PBW with a PEEP of 8–10cmH20 for the same
length of time. The results revealed a dramatic increase in
the number of eligible lung donors (54% versus 95%, P<
0.001), as well as in the number of patients in whom lungs
were harvested (27% versus 54%, P = 0.004), suggesting
either a decrease in lung damage due to a less exposure to
injurious standard VT ventilation or better lung recruitment
with higher levels of PEEP.
The data for high-risk surgical patients also appears to
favor the use of prophylactic lung protective ventilation. A
trial by Lee et al. in a surgical ICU, excluding neurotrauma
and cardiac surgery patients, randomized 103 patients to
12mL/kg versus 6mL/kg. They documented a reduction
in pulmonary infections, a trend towards a reduced ICU
length of stay and a reduced duration of intubation in
the group with lower VTs [41]. Fern´ andez-P´ erez et al.
analyzed, via retrospective chart review, 170 patients under-
going pneumonectomy. The analysis showed that of all the
patients 18% developed respiratory failure and 50% of these
developed ALI. Those who developed respiratory failure had
higher intraoperative VTs compared to those who did not4 Critical Care Research and Practice
Table 2: Impact of ventilation strategy for critically ill intensive care unit patients.
Reference
(year)
Type of patients
(n) VT-PEEP Main results
mL/kg cmH2O
Intensive care unit patients
Gajic et al. (2004) [35]
Cohort Medical/surgical (332) OR for ALI = 1.3 for every 1mL > 6
mL/kg
Gajic et al. (2005) [36]
Retrospective
Medical/surgical
(3261) OR for ARDS = 2.6 with VT > 700mL
Determann et al. (2010)
[37]R C T
Medical/surgical
(150) VT 10 versus 6
Relative risk for developing ALI was
5.1 with high VT
↓ inﬂammatory markers
Mascia et al. (2010) [38]
RCT
Organ Donors
(118)
VT 10–12-PEEP 3–5
VT 6–8-PEEP 8–10
More eligible and harvested lungs with
low VT
RCT: randomized controlled studies. MV: mechanical ventilation. VT: tidal volume. ALI: acute lung injury. ARDS: acute respiratory distress syndrome.
(8.3 versus 6.7mL/kg P<0.001, OR 1.56) [42]. Michelet
et al. performed a randomized trial with 52 cancer patients
undergoing esophagectomy, comparing a VT of 9mL/kg
and zero PEEP (ZEEP) versus 9mL/kg during two-lung
ventilation which was reduced to 5mL/kg during one-lung
ventilation with a PEEP of 5cmH20[ 43]. Postoperatively, a
reduction in inﬂammatory cytokines and, more importantly,
improved PaO2/FiO2 ratios, and a reduction in the duration
of intubation were found in the reduced VT group. A small
randomized trial of 40 elderly patients undergoing major
abdominal surgery compared a VT of 10mL/kg and ZEEP
with 6mL/kg and 12cmH 20 of PEEP with recruitment
maneuvers. The major ﬁnding was that an “open lung”
protective ventilation strategy was tolerated hemodynami-
cally, and despite no change in inﬂammatory biomarkers,
the low VT-high PEEP group had improved intraoperative
oxygenation and respiratory mechanics [44].
Conﬂicting data does exist for high-risk surgical patients.
A large prospective case control trial of 4420 consecutive
patients undergoing major surgery lasting for >3h o u r s
examinedintraoperativeventilatorsettingsandtheincidence
of ALI, and survival. Three percent of patients (n = 83)
developed ALI and it was found that the mean airway pres-
sure in the ﬁrst hour of ventilation correlated with the devel-
opmentofALIbutnocorrelationwasdemonstratedbetween
VTorPEEPandthedevelopmentofALI[45].Inaddition, in
a recent retrospective study of 89 surgical patients admitted
withrespiratory failure,Hughes etal. were unable toﬁnd any
correlation between intraoperative VT and the development
of ARDS, although most patients in this study were being
ventilated with a VT of <10mL/kg PBW [46].
Cardiac surgery patients seem to be at higher risk of ac-
quiring ALI/ARDS due to the inﬂammatory changes caused
by cardiopulmonary bypass [47, 48]. In cardiac surgery, a
number of studies have been performed examining clinical
and biochemical changes associated with varying VTs. A
reduction in plasma and bronchoalveolar cytokine levels was
seen when using a low VT strategy (8mL/kg and PEEP
of 10 compared to 10–12mL/kg and PEEP of 2-3cmH2O)
in 40 randomized elective coronary artery bypass surgeries
[49].Othersmalltrialsrevealedsimilarreductionsininﬂam-
matory markers, although with conﬂicting results [50–52].
Sundar et al. randomized elective cardiac surgery patients to
receive a VT of either 6 or 10mL/kg PBW. Patients receiving
lowerVTsweremorelikelytobeliberatedfromventilationat
6hrs after surgery. It is not clear if these eﬀects were related
toastrategyofprotectiveventilationoriftheywereduetoan
increase in respiratory drive by the eﬀect of low VT inducing
higher PaCO2 and lower pH levels. Moreover, fewer patients
with low VT required reintubation [53].
The largest study concerning cardiac surgery patients
examined 3434 consecutive bypass, valve or combined
procedures, and the immediate postoperative VTs used. VTs
were divided into low (<10mL/kg PBW), traditional (10–
12mL/kg PBW), or high (>12mL/kg PBW). A multivariate
analysis comparing high versus low VT revealed an increased
risk of mechanical ventilation lasting more than 24hrs (OR
2.4, P = 0.001), hemodynamic instability for more than
48hrs (OR 1.8, P = 0.007), and a prolonged ICU stay
for more than 7 days (OR 1.8, P = 0.045) in the higher
VT group. In addition, risk factors for the use of high VT
included a BMI > 30 (OR 6.2, P<0.0001) and female sex
(OR 4.3, P<0.0001) [54].
The data for the use of low VT in patients undergoing
lower-risk elective operations is less evident. A trial of 39
low-risk patients undergoing elective surgery randomized
patients to 15mL/kg PBW with ZEEP, 6mL/kg PBW with
ZEEP, or 6mL/kg PBW with a PEEP of 10cmH20. Plasma
cytokine levels were measured after 1 hour of mechanical
ventilation. The authors were unable to ﬁnd any diﬀerence
in inﬂammatory biomarkers in any of the groups [55].
In another small trial, investigators randomized patients
undergoingelectivethoracotomytoreceiveaVTof12mL/kg
P B Ww i t hZ E E Pv e r s u s6 m L / k gP B Ww i t h1 0 c m H 2Oo f
PEEP and also randomized patients undergoing elective
laparotomy to a VT of 15mL/kg PBW with ZEEP or
6mL/kg PBW with 10cmH2Oo fP E E P .A f t e r3h o u r so f
ventilation, inﬂammatory mediators including TNF, IL-1,
6, 8, 10, and 12 were measured in both the plasma and
trachealsecretions.TheytoowereunabletoﬁndasigniﬁcantCritical Care Research and Practice 5
diﬀerence between the two groups [26]. Whether cytokine
levels are a meaningful endpoint or whether or not 3
hours is suﬃcient to ﬁnd a diﬀerence may both be limiting
factors. Choi et al. analyzed pulmonary inﬂammation in
the bronchoalveolar ﬂuid of 40 patients undergoing elective
complex abdominal surgeries with a minimum duration of
5hrs.Patientswererandomizedto12mL/kgPBWwithZEEP
or 6mL/kg PBW with 10cmH20 of PEEP. Although no
clinical diﬀerences were found between groups (the study
was not powered to ﬁnd clinical diﬀerences), they did ﬁnd
a signiﬁcant increase in procoagulant biomarkers in patients
ventilated with elevated VTs [56].
4. The ClinicalApplication of Lung
ProtectiveVentilation
The overall goal of lung protective ventilation is to minimize
lung trauma by avoiding both overdistention (and associated
elevated pressure) and repetitive alveolar collapse, while
providing adequate oxygenation and ventilation. What is
important to note is that the peak pressure is not necessarily
the distending pressure transmitted to the alveoli, and
consequently elevated peak pressures are not detrimental
to the lung per se. The actual distending pressure of the
alveoli is better reﬂected by the plateau pressure, which can
be easily achieved by performing an inspiratory pause on
the ventilator in a volume-controlled mode. In truth, the
transmitted pressure or transpulmonary pressure, calculated
as the diﬀerence between the alveolar and pleural pressures
[57], is what causes alveolar trauma, although it can be
more diﬃcult to measure and monitor at the bedside. As
such, to minimize the risk of developing VILI, one should
monitorandmaintaintheplateaupressurebelow30cmH20,
unless your ICU has the capability of reliably measuring
transpulmonary pressure.
To avoid alveolar overdistention and volutrauma, a VT
of 6mL/kg PBW is recommended for ALI or ARDS patients.
Of note, it is crucial that the PBW and not the actual body
weight (ABW) be used to calculate tidal volume. The use
of ABW may overestimate the required VT [58]. In patients
without ALI/ARDS current evidence suggests that a VT
between 6–8mL/Kg PBW in patients at risk of ALI/ARDS
should be used, and, in patients without risk factors, a VT
≤ 10mL/kg PBW is appropriate.
PEEP has several beneﬁts in lung protective ventilation.
PEEP is used to keep the alveoli open and to minimize
atelectotrauma: a “lung-open” strategy. PEEP also protects
fromalveolarderecruitmentandsecondaryhypoxemiawhile
minimizing the amount of inspired oxygen required, thereby
avoiding denitrogenation atelectasis and potential oxygen
toxicity [59]. Another way to avoid atelectasis is to reduce
the FiO2, as levels above 60% can cause denitrogenation
atelectasis [60–62]. To this end, the SpO2 target must be
reduced in the case of ARDS patients to 88–92% [33, 63].
From clinical data, PEEP ranging between 5 and 24cmH20
is not only safe but is associated with improved oxygenation,
less need of rescue therapy for refractory hypoxemia, and
reduced multiorgan failure [29, 30, 34]. Although the opti-
mal level of PEEP is still controversial, the use of zero PEEP
(ZEEP) has been associated with worse outcomes, including
increased hypoxemia, ventilator-associated pneumonia, and
hospital mortality [64, 65]. How and to what level PEEP
should be titrated to remains unclear. Some authors have
used pressure-volume curves and the lower inﬂection point
to titrate PEEP with good results [32]. The ALVEOLI and
LOVS trials used a set PEEP sliding scale based on the
FiO2 with a maximum plateau pressure of 30 or 40 cmH20,
respectively [29, 30]. The EXPRESS trial used the maximum
amountofPEEPaslongasthepeakpressureremainedbelow
30cmH20[31].InapilotstudybyTalmoretal.patientswith
ARDS were randomized to a strategy of esophageal balloon
directed estimation of pleural pressures and consequently
used the calculated transpulmonary pressures to guide PEEP
titration. The control group was managed as per the ARDS
Network protocol including a PEEP sliding scale based on
FiO2. This single centre pilot trial demonstrated a signiﬁcant
improvement in oxygenation, pulmonary compliance, and
28-day mortality [66]. In patients without ALI/ARDS,
PEEP levels between 5 and 12cmH2O have been used in
conjunction with low tidal volume and usually ≥8cmH 2O
(Tables 1 and 2). Therefore we suggest starting with a PEEP
levelof8cmH2Oandtitrating upor downdepending onthe
FiO2 and the hemodynamic status of the patient.
Due to the reduction in VT and subsequent minute
ventilation, carbon dioxide levels are often elevated in these
patients and the hypercapnia tolerated, a concept referred to
as permissive hypercapnia [67]. To avoid severe respiratory
acidosis (ph < 7.20), the respiratory rate needs to be
increased, often up to 30breaths/min. For patients with
risk factors for ARDS such as sepsis, a starting respiratory
rate of 20 or more is suggested to avoid severe acidosis
following initial intubation and ventilation with 6–8mL/kg
PBW. In addition, the humidiﬁcation system used with the
ventilator is particularly important and can be a signiﬁcant
contributor to increased respiratory acidosis. To reduce the
severity of hypercapnia, reduction of dead space can be easily
accomplished by using a heated humidiﬁer instead of a heat
and moisture exchanger [68–74]( Table 3).
5. Challenges and Controversyto the Use
of ProtectiveVentilation
Although convincing data has accumulated in the literature,
protective ventilation is not as widely used as it should be,
and there remains some controversy in the most appropriate
way to prescribe and titrate lung protective ventilation [75].
Should all patients with ARDS receive the same 6mL/kg
PBW of ventilation? This question has been raised by
a number of leading authors in the ﬁeld of mechanical
ventilation and ARDS and remains controversial [76–78].
Although the results of the ARMA trial were positive, other
similar smaller trials were not [11–15], and there is evidence
thatthecorrelationbetweenPBW,height,andlungvolumeis
lost in patients with ARDS as compared to normal controls
[79, 80]. Furthermore, the lung strain and potential injury
induced by a given VT is dependant on the amount of
“baby lung,” and this is highly variable between patients
[81, 82]. In an editorial in 2005, Deans et al. highlight the6 Critical Care Research and Practice
Table 3: Recommended initial lung protective mechanical ventilator settings following intubation in patients without ALI/ARDS.
Patients without risk factors for ALI/ARDS Patients with risk factors for ALI/ARDS∗
VT (mL/kg PBW) <10 6–8
Respiratory rate (breath/min) ≥15 ≥20
PEEP (cmH2O) ≥5 ≥8
FiO2 (%) <60∗∗ <60∗∗
Target SpO2 (%)† 92–96 92–96
Humidiﬁcation device HME∗∗∗ HME∗∗∗
∗Major risk factors for acquired ALI/ARDS include: Sepsis, trauma, blood transfusions, cardiopulmonary bypass, and others.
∗∗The lowest FiO2 to achieve an acceptable SpO2 should be used.
∗∗∗The heterogeneity of the HME should be known, and, if severe respiratory acidosis occurs, heated humidiﬁers should be used instead [68].
†If FiO2 requirements are above 60%, a target SpO2 of 88–92% should be tolerated [63].
VT: tidal volume, PBW: predicted body weight, and HME: heat and moisture exchangers.
relationship between pulmonary compliance and mortality
in the ARMA trial. Patients with a low compliance had a
higher mortality if receiving a higher VT. However, patients
with higher baseline pulmonary compliance had an increase
in mortality when receiving a lower VT therefore suggesting
that all patients should not receive the same prescribed VT
[76]. Gattinoni suggests a tailored approach to setting up
mechanical ventilation with measurements of lung volume
and transpulmonary pressures, although her admits that,
shouldthesemethodsnotbepossibleinanindividualcentre,
a lower VT compared to a higher VT is almost always more
appropriate [77].
There are multiple reasons why clinicians underuse low-
VT ventilation. There is a general underrecognition of ALI
and ARDS in clinical practice, and, consequently, many
patients who could beneﬁt from this therapy are not receiv-
ing appropriate treatment [75, 83]. In an attempt to identify
patients less likely to receive lung protective ventilation,
a recent study found that demographic factors including
height, race, and lower simpliﬁed acute physiology II (SAPS
II) scores were associated with underuse of low-VT ventila-
tion [84].
The use of protective ventilation does require more ad-
vanced knowledge of ventilator management, and, depend-
ing on the availability of local expertise, clinicians may
be unable or reluctant to make the necessary adjustments.
In order to maintain adequate minute ventilation, one is
often required to aggressively increase the respiratory rate,
sometimes above 30breaths/min. This may lead to the devel-
opment of dynamic hyperinﬂation and auto-PEEP which
can have signiﬁcant negative respiratory and hemodynamic
consequences[85]. Due to short time constants and low lung
compliance in patients with ALI/ARDS, this risk is usually
limited below 30breaths/minute [86]. However, the ability
to recognize patients at risk for auto-PEEP as well as to
accurately recognize the presence of dynamic hyperinﬂation
from abnormal ventilator waveforms is fundamental to safe
clinical practice [87]. Quickly analyzing the ﬂow and pres-
surewaveformsofmostventilatorscanidentifymostpatients
with dynamic hyperinﬂation or auto-PEEP. When the end-
expiratory ﬂow is below the zero baseline, dynamic hyper-
inﬂation exists. By performing an expiratory ﬂow occlusion
maneuver, the static auto-PEEP can be measured which cor-
responds to the mean PEEP of all lung units [88].
An additional concern associated with low tidal volume
ventilation is the development of signiﬁcant patient-ventila-
tor dyssynchrony. Dyssynchrony can occur in any patient
whoismechanicallyventilatedandinparticularpatientswho
arenotsedatedorwhohaveahighdrivetobreathe.Although
many types of patient-ventilator dyssynchrony occur, the
most important for ARDS patients relates to ﬂow dyssyn-
chrony, which occurs when the volume or ﬂow delivered to
thepatient failsto meet the respiratory demand or theneural
drive to breathe [89]. Dyssynchrony cannot only cause
intense patient anxiety and a sense of dyspnea, which occurs
commonly in ventilated patients, but can increase the work
of breathing and cause respiratory muscle fatigue [90–92].
In order to minimize patient-ventilator dyssynchrony, the
clinician must routinely examine the patient for signs of
distress and the ventilator for abnormal waveforms [93].
Titrating the inspiratory ﬂow based on both the physical
exam and waveform analysis can help minimize the dyssyn-
chrony and usually requires a ﬂow of at least 80L/min but
should be individualized for each patient and titrated when
needed. The use of a decelerating ﬂow waveform can also
be used to deliver high inspiratory ﬂows with a relatively
longer inspiratory time which can avoid the problem of
double triggering that occurs with the shorter inspiratory
times associated with a square waveform [92]. Some patients
with high minute ventilation remain dyssynchronous with
tidal volumes of 6mL/kg PBW and either require heavy
sedation, paralysis, or an increase in VT. However, in centers
experienced with ALI/ARDS, a low tidal volume strategy did
not overall increase the use of sedation, and the recent large
randomizedtrialexaminingtheuseofneuromuscularblock-
ersinacuteARDShasalleviatedsomeconcernsregardingthe
risks of sedation and paralysis if needed [94, 95]. Moreover,
in the initial ARMA study, patients were allowed an increase
in VT to 8mL/kg PBW if signiﬁcant dyssynchrony occurred,
as long as the plateau pressures remained below 30cmH2O,
and in a study by Kallet et al., a tidal volume of 8mL/kg PBW
was associated with a reduction in the work of breathing;
therefore this may be an appropriate maneuver to avoid
severe patient-ventilator dyssynchrony [91].Critical Care Research and Practice 7
Figure 1: iAnthropometer II smartphone application for the assessment of PBW [113]. This smartphone application facilitates the calcula-
tion of patient height via digital measurement of leg length and subsequently calculates the PBW and the appropriate corresponding VT.
Physicians’additionalconcernsforhypercapnia,acidosis,
and hypoxemia have also led to barriers in implementing
protective ventilation [96]. Permissive hypercapnia should
be tolerated in patients undergoing protective ventilation
although to what degree is still unclear. In an attempt to
determine the safety and lung protective eﬀects of extreme
hypercapnia, surfactant depleted rabbits were ventilated
with progressively lower VTs and targeted a progressively
higher PaCO2. There was signiﬁcantly less lung injury when
ventilated with a VT of 4-5mL/kg and an associated PaCO2
of 80mmHg (pH = 7.09) compared to 8–10mL/kg with a
PaCO2 of 40mmHg (pH = 7.29). Even in animals with a
VT of 3-4mL/kg and a PaCO2 of 120mmHg (pH = 6.98)
or 2-3mL/kg and a PaCO2 of 160mmHg (pH = 6.91),
lung protection was preserved and without hemodynamic
consequences [97]. Knowledge of the potential adverse
eﬀects of hypercapnia on the cardiovascular, respiratory, and
other organ systems is still critical in order to avoid serious
adverse eﬀects. Some important physiologic considerations
due to hypercarbia include the negative eﬀects of acidosis
on cardiovascular hemodynamics, pulmonary hypertension
due to pulmonary arterial vasoconstriction, and elevation of
intracranialpressureduetocerebralvasodilation[67].Inour
practice we tolerate respiratory acidosis with pH values as
low as 7.20 in very severe ARDS patients after dead space
minimization and optimization of the respiratory rate have
been performed, but the lower acceptable value is not clearly
determined.
Hypoxia secondary to derecruitment atelectasis associ-
ated with low VT ventilation, although a concern, should
be placed in the appropriate context. It is recommended
to target a SpO2 of 88–92% in ARDS patients in order to
minimizethedeliveredFiO2,andtheuseofbothrecruitment
maneuvers and higher levels of PEEP in nonhypovolemic
patients may be helpful to reduce FiO2 requirements in
certainclinicalsituations(followingventilatordisconnectfor
suctioning or transport) but should not be systematically
used. In the landmark ARDS Network study, the reduction
in VT was associated with a lower PaO2, which did not
impede the reduction in overall mortality [11]. Indeed,
clinicians often target oxygen levels that are excessively
high. A recent analysis examined clinicians’ response to
hyperoxia in 5498 mechanically ventilated patients. In this
study, 22% of arterial blood gases had PaO2 levels greater
than 120mmHg, and in only 25% of those blood gases, the
FiO2 levels were adjusted [98]. Studies examining the eﬀects
of hyperoxia in mechanically ventilated animal lungs have
shown that high FiO2 is associated with increased oxidative
injury, impaired immunity, and death [99]. Large clinical
trials in humans are unfortunately lacking. However, human
data examining the physiologic eﬀects of hyperoxia does
exist and includes impaired myocardial blow ﬂow, increased
myocardial consumption, and reduced cerebral blood ﬂow
d u et oa r t e r i a lv a s o c o n s t r i c t i o n[ 100–102]. Thus, in patients
ventilated without lung injury, where hyperoxia is easily
obtained, one should minimize FiO2 levels to avoid potential
systemic oxygen toxicity.
It takes many years to implement research ﬁndings
into clinical practice, a process referred to as knowledge
translation [103, 104]. Indeed, despite the evidence showing
that a reduced VT strategy is associated with improved
outcomes, clinicians still routinely use VTs greater than
10mL/kg [105, 106]. Eight years following the original
landmark ARDS Network paper, Umoh et al. still found that
only 46% of eligible patients received low VT ventilation in
nine ICUs of three diﬀerent teaching hospitals [106]. Studies
showing the best implementation of protective ventilation
were carried out in centers participating in mechanical
ventilation networks [107], but this does not reﬂect real-
life practice, where protective ventilation in ARDS patients
is even less successfully applied [108].
Even when ICU physicians attempt to use protective ven-
tilation in their everyday practice, the use of actual instead
of PBW in the calculation of VT is a frequent error, leading
to overtreatment with higher VTs. PBW in men is calculated
as 50 (45 in women) + 0.91 (Height cm −152.4) [11]. In
many instances, the height of the patient is not immediately
known. This is especially true outside of the surgical ICU
(i.e., emergency department, postanesthesia recovery room
or medical ICU) because surgical ICUs are more likely to
have height and weight measurements due to the operative
record [58]. In addition, visual estimation of patient height
and weight is known to be inaccurate [109–111], and shorter
patients, often women, tend to be more severely aﬀected
[54, 112]. The ability to rapidly calculate PBW at the
bedside is important. Novel devices such as applications on8 Critical Care Research and Practice
smartphones, (e.g., iAnthropometer ICU), where one can
quickly take a bedside picture of a patients leg and calculate
the patients height based on validated formulas, and auto-
maticallyderive the PBWandsubsequentVTs, arepromising
tools (Figure 1)[ 113]. This application was more accurate
at calculating patient height than both the method of visual
estimation and supine in-bed tape measurement [114].
Automated mechanical ventilation systems are another
way to help implement protective ventilation. In a pre-
liminary study, we evaluated the new Intellivent system
(Hamilton medical, Bonaduz, Switzerland) in patients after
cardiac surgery [115]. We showed that VTs were auto-
matically reduced below 10mL/kg of PBW after a few
minutes of mechanical ventilation, and the respiratory rate
was automatically increased to maintain a stable minute
ventilation. These closed-loop systems will likely become
more widely available given the results of promising initial
clinical evaluations [116–119].
6. Conclusion
The routine use of protective ventilation in all ventilated
patients is not yet recommended, but more liberal use of
this currently restricted treatment may be justiﬁed. Schultz
et al. recommend a VT of 6mL/kg PBW in patients with
ALI/ARDS or in patients with risk factors for the develop-
ment of lung injury [120], such as multiple transfusions,
trauma, sepsis, or high-risk surgery. In other mechanically
ventilated patients, they recommend the use of VTs below
10mL/KgPBWfromtheinitiationofmechanicalventilation.
Thisisinagreementwithourﬁndingsinpatientsundergoing
cardiac surgery [54]. Whether there is a beneﬁt in other
subgroups of patients, such as those intubated for congestive
heart failure or other high-risk surgeries or trauma patients,
is unknown, and further studies are needed. Moreover, it
remains unclear if and how VT should be individualized.
As technology improves, measurements of lung volume and
transpulmonary pressures may become more technically
feasible, aﬀordable, and reliable. However for the majority
of clinicians this practice is currently restricted to selected
specialized centers and to the ﬁeld of research.
Given the unpredictability of developing ALI/ARDS
throughout the course of apost illness, a ventilation strategy
that incorporates low VT and high PEEP in the majority
of intubated patients is warranted and is in agreement with
other authors [78, 104]. This paradigm shift in the manage-
mentofmechanicalventilationchangesthegoaloftreatment
from limiting disease progression (i.e., in patients already
suﬀering from ALI/ARDS) to disease prevention. Patients
whomaynotbeneﬁtfromthisstrategyarethosewhoareoth-
erwise healthy and are undergoing routine elective surgery.
Given the proven safety of this approach, the physiologic
rationale, and the current evidence, mechanically venti-
lated patients who do not have ARDS but who remain
at risk for ALI/ARDS should be ventilated with a VT
between 6–8mL/kg PBW while those without risk factors
should receive ≤10mL/kg PBW to prevent progressive lung
injury. Compared to patients with ARDS who often have
a signiﬁcant amount of recruitable lung units and higher
oxygenation requirements, the amount of PEEP required for
patients without ARDS is therefore much less, and based on
current evidence, we suggest an initial setting of 8cmH2O
which should be titrated based on the individual patients
oxygenation requirements.
There is clear evidence from large randomized trials that
protective ventilation can reduce morbidity and mortality
in patients with ALI and ARDS. More recently, signiﬁcant
data has emerged which suggests that a protective ventilation
strategy in patients without ALI/ARDS may lead to a
reduction in inﬂammation, less organ dysfunction, and less
ALI. Patients at highest risk are those within the ICU with
sepsis, trauma, or shock, high-risk surgical patients, or those
undergoing cardiopulmonary bypass. How this therapy
should be individualized to patients with variable respiratory
and cardiovascular physiology remains controversial and
future studies will be required to identify if all patients
undergoingmechanicalventilationwouldbeneﬁtfromlower
tidal volumes, lower plateau pressures, and higher levels of
PEEP.
References
[1] H. H. Webb and D. F. Tierney, “Experimental pulmonary
edema due to intermittent positive pressure ventilation
with high inﬂation pressures. Protection by positive end
expiratory pressure,” American Review of Respiratory Disease,
vol. 110, no. 5, pp. 556–565, 1974.
[2] D. Dreyfuss, P. Soler, G. Basset, and G. Saumon, “High
inﬂation pressure pulmonary edema. Respective eﬀects of
high airway pressure, high tidal volume, and positive end-
expiratory pressure,” American Review of Respiratory Disease,
vol. 137, no. 5, pp. 1159–1164, 1988.
[3] A.S.Slutsky,“Basicscienceinventilator-inducedlunginjury:
implicationsforthebedside,”AmericanJournalofRespiratory
and Critical Care Medicine, vol. 163, no. 3 I, pp. 599–600,
2001.
[4] S. M. Tenney and J. E. Remmers, “Comparative quantitative
morphology of the mammalian lung: diﬀusing area,” Nature,
vol. 197, no. 4862, pp. 54–56, 1963.
[5] L. B. Ware and M. A. Matthay, “The acute respiratory distress
syndrome,”NewEnglandJournalofMedicine,vol.342,no.18,
pp. 1334–1349, 2000.
[6] J. T. Granton and A. S. Slutsky, “Ventilator-induced lung
injury,” in Principles of Critical Care, J. Hall, G. Schmidt, and
L. Wood, Eds., pp. 499–514, McGraw-Hill, 2005.
[7] D.DreyfussandG.Saumon,“Ventilator-inducedlunginjury:
lessons from experimental studies,” American Journal of
Respiratory and Critical Care Medicine, vol. 157, no. 1, pp.
294–323, 1998.
[8] C. C. dos Santos and A. S. Slutsky, “Protective ventilation of
patients with acute respiratory distress syndrome,” Critical
Care, vol. 8, no. 3, pp. 145–147, 2004.
[9] L. N. Tremblay and A. S. Slutsky, “Ventilator-induced injury:
from barotrauma to biotrauma,” Proceedings of the Associa-
tion of American Physicians, vol. 110, no. 6, pp. 482–488,
1998.
[10] F. B. Pl¨ otz, A. S. Slutsky, A. J. Van Vught, and C. J. Heijnen,
“Ventilator-induced lung injury and multiple system organ
failure: a critical review of facts and hypotheses,” Intensive
Care Medicine, vol. 30, no. 10, pp. 1865–1872, 2004.Critical Care Research and Practice 9
[ 1 1 ]R .G .B r o w e r ,M .A .M a t t h a y ,A .M o r r i s ,D .S c h o e n f e l d ,B .
T. Thompson, and A. Wheeler, “Ventilation with lower tidal
volumesascomparedwithtraditionaltidalvolumesforacute
lunginjuryandtheacuterespiratorydistresssyndrome,”New
England Journal of Medicine, vol. 342, no. 18, pp. 1301–1308,
2000.
[12] M. B. P. Amato, C. S. V. Barbas, D. M. Medeiros et al., “Eﬀect
of a protective-ventilation strategy on mortality in the acute
respiratorydistresssyndrome,”NewEnglandJournalofMedi-
cine, vol. 338, no. 6, pp. 347–354, 1998.
[13] L. Brochard, F. Roudot-Thoraval, E. Roupie et al., “Tidal
volume reduction for prevention of ventilator-induced lung
injury in acute respiratory distress syndrome,” American
JournalofRespiratoryandCriticalCareMedicine,vol.158,no.
6, pp. 1831–1838, 1998.
[14] T. E. Stewart, M. O. Meade, D. J. Cook et al., “Evaluation of a
ventilation strategy to prevent barotrauma in patients at high
risk for acute respiratory distress syndrome,” New England
Journal of Medicine, vol. 338, no. 6, pp. 355–361, 1998.
[15] P. Q. Eichacker, E. P. Gerstenberger, S. M. Banks, X. Cui,
and C. Natanson, “Meta-analysis of acute lung injury and
acute respiratory distress syndrome trials testing low tidal
volumes,” American Journal of Respiratory and Critical Care
Medicine, vol. 166, no. 11, pp. 1510–1514, 2002.
[16] A. Esteban, A. Anzueto, F. Frutos et al., “Characteristics and
outcomes in adult patients receiving mechanical ventilation:
a28-dayinternationalstudy,”JournaloftheAmericanMedical
Association, vol. 287, no. 3, pp. 345–355, 2002.
[17] P. Wongsurakiat, D. J. Pierson, and G. D. Rubenfeld, “Chang-
ing pattern of ventilator settings in patients without acute
lung injury: changes over 11 years in a single institution,”
Chest, vol. 126, no. 4, pp. 1281–1291, 2004.
[18] H. H. Bendixen, J. Hedley-whyte, and M. B. Laver, “Impaired
oxygenation in surgical patients during general anesthesia
with controlled ventilation,” The New England Journal of
Medicine, vol. 269, pp. 991–996, 1963.
[19] R. D. Miller, Anesthesia, Elsevier/Churchill Livingstone, Phil-
adelphia, Pa, USA, 6th edition, 2005.
[20] D. G. Ashbaugh, D. B. Bigelow, T. L. Petty, and B. E. Levine,
“Acute respiratory distress in adults,” Lancet, vol. 2, no. 7511,
pp. 319–323, 1967.
[21] A. Kumar, K. J. Falke, B. Geﬃn et al., “Continuous positive-
pressure ventilation in acute respiratory failure,” New Eng-
land Journal of Medicine, vol. 283, no. 26, pp. 1430–1436,
1970.
[22] K. J. Falke, H. Pontoppidan, A. Kumar, D. E. Leith, B. Geﬃn,
and M. B. Laver, “Ventilation with end-expiratory pressure
in acute lung disease,” Journal of Clinical Investigation, vol.
51, no. 9, pp. 2315–2323, 1972.
[23] P. M. Suter, B. Fairley, and M. D. Isenberg, “Optimum end-
expiratory airway pressure in patients with acute pulmonary
failure,” New England Journal of Medicine, vol. 292, no. 6, pp.
284–289, 1975.
[24] M. Mathru, T. L. K. Rao, and B. Venus, “Ventilator-induced
barotrauma in controlled mechanical ventilation versus
intermittent mandatory ventilation,” Critical Care Medicine,
vol. 11, no. 5, pp. 359–361, 1983.
[25] C. C. dos Santos and A. S. Slutsky, “Invited review: mech-
anisms of ventilator-induced lung injury: a perspective,”
Journal of Applied Physiology, vol. 89, no. 4, pp. 1645–1656,
2000.
[26] H. Wrigge, U. Uhlig, J. Zinserling et al., “The eﬀects of diﬀer-
ent ventilatory settings on pulmonary and systemic inﬂam-
matory responses during major surgery,” Anesthesia and An-
algesia, vol. 98, no. 3, pp. 775–781, 2004.
[27] K. G. Hickling, “Low volume ventilation with permissive
hypercapnia in the Adult Respiratory Distress Syndrome,”
Clinical Intensive Care, vol. 3, no. 1, pp. 67–78, 1992.
[ 2 8 ] K .G .H i c k l i n g ,J .W a l s h ,S .H e n d e r s o n ,a n dR .J a c k s o n ,“ L o w
mortality rate in adult respiratory distress syndrome using
low-volume, pressure-limited ventilation with permissive
hypercapnia:aprospectivestudy,”CriticalCareMedicine,vol.
22, no. 10, pp. 1568–1578, 1994.
[29] M. O. Meade, D. J. Cook, G. H. Guyatt et al., “Ventilation
strategy using low tidal volumes, recruitment maneuvers,
and high positive end-expiratory pressure for acute lung
injuryandacuterespiratorydistresssyndrome:arandomized
controlled trial,” Journal of the American Medical Association,
vol. 299, no. 6, pp. 637–645, 2008.
[30] R. G. Brower, P. N. Lanken, N. MacIntyre et al., “Higher ver-
sus lower positive end-expiratory pressures in patients with
the acute respiratory distress syndrome,” New England Jour-
nal of Medicine, vol. 351, no. 4, pp. 327–336, 2004.
[31] A. Mercat, J.-C. M. Richard, B. Vielle et al., “Positive
end-expiratory pressure setting in adults with acute lung
injuryandacuterespiratorydistresssyndrome:arandomized
controlled trial,” Journal of the American Medical Association,
vol. 299, no. 6, pp. 646–655, 2008.
[32] J. Villar, R. M. Kacmarek, L. P´ erez-M´ endez, and A. Aguirre-
Jaime, “A high positive end-expiratory pressure, low tidal
volume ventilatory strategy improves outcome in persistent
acute respiratory distress syndrome: a randomized, con-
trolled trial,” Critical Care Medicine, vol. 34, no. 5, pp. 1311–
1318, 2006.
[ 3 3 ]R .P .D e l l i n g e r ,M .M .L e v y ,a n dJ .M .C a r l e t ,“ S u r v i v i n g
Sepsis Campaign: international guidelines for management
of severe sepsis and septic shock: 2008,” Critical Care
Medicine, vol. 36, no. 1, pp. 296–327, 2008.
[34] M. Briel, M. Meade, A. Mercat et al., “Higher vs lower posi-
tive end-expiratory pressure in patients with acute lung inju-
ryandacute respiratorydistresssyndrome: systematicreview
and meta-analysis,” Journal of the American Medical Associa-
tion, vol. 303, no. 9, pp. 865–873, 2010.
[35] O. Gajic, S. I. Dara, J. L. Mendez et al., “Ventilator-associated
lung injury in patients without acute lung injury at the onset
ofmechanicalventilation,”CriticalCareMedicine,vol.32,no.
9, pp. 1817–1824, 2004.
[36] O. Gajic, F. Frutos-Vivar, A. Esteban, R. D. Hubmayr, and A.
Anzueto, “Ventilator settings as a risk factor for acute respir-
atory distress syndrome in mechanically ventilated patients,”
Intensive Care Medicine, vol. 31, no. 7, pp. 922–926, 2005.
[37] R. M. Determann, A. Royakkers, E. K. Wolthuis et al., “Ven-
tilation with lower tidal volumes as compared with conven-
tional tidal volumes for patients without acute lung injury:
a preventive randomized controlled trial,” Critical Care, vol.
14, no. 1, article R1, 2010.
[38] L. Mascia, D. Pasero, A. S. Slutsky et al., “Eﬀect of a lung
protective strategy for organ donors on eligibility and avail-
ability of lungs for transplantation: a randomized controlled
trial,” Journal of the American Medical Association, vol. 304,
no. 23, pp. 2620–2627, 2010.
[39] United Network for Organ Sharing Critical pathway for the
organ donor, http://www.unos.org/docs/Critical Pathway
.pdf.
[40] S.D.Shemie,H.Ross,J.Pagliarelloetal.,“Organdonorman-
agementinCanada:recommendationsoftheforumonMed-
ical Management to Optimize Donor Organ Potential,” Ca-
nadian Medical Association Journal, vol. 174, no. 6, pp. S13–
S32, 2006.10 Critical Care Research and Practice
[41] P. G. Lee, C. M. Helsmoortel, S. M. Cohn, and M. P. Fink,
“Are low tidal volumes safe?” Chest, vol. 97, no. 2, pp. 430–
434, 1990.
[42] E. R. Fern´ andez-P´ erez, M. T. Keegan, D. R. Brown, R. D.
Hubmayr, and O. Gajic, “Intraoperative tidal volume as a
risk factor for respiratory failure after pneumonectomy,”
Anesthesiology, vol. 105, no. 1, pp. 14–18, 2006.
[43] P.Michelet,X.B.D’Journo,A.Rochetal.,“Protectiveventila-
tion inﬂuences systemic inﬂammation after esophagectomy:
a randomized controlled study,” Anesthesiology, vol. 105, no.
5, pp. 911–919, 2006.
[44] T. N. Weingarten, F. X. Whalen, D. O. Warner et al., “Com-
parison of two ventilatory strategies in elderly patients
undergoing major abdominal surgery,” British Journal of
Anaesthesia, vol. 104, no. 1, pp. 16–22, 2010.
[45] E. R. Fern´ andez-P´ erez, J. Sprung, B. Afessa et al., “Intraop-
erative ventilator settings and acute lung injury after elective
surgery: a nested case control study,” Thorax,v o l .6 4 ,n o .2 ,
pp. 121–127, 2009.
[46] C. G. Hughes, L. Weavind, A. Banerjee, N. D. Mercaldo, J.
S. Schildcrout, and P. P. Pandharipande, “Intraoperative risk
factors for acute respiratory distress syndrome in critically ill
patients,” Anesthesia and Analgesia, vol. 111, no. 2, pp. 464–
467, 2010.
[47] D. J. Kor, D. O. Warner, A. Alsara et al., “Derivation and
diagnostic accuracy of the surgical lung injury prediction
model,” Anesthesiology, vol. 115, no. 1, pp. 117–128, 2011.
[48] O.J.Warren,A.J.Smith,C.Alexiouetal.,“Theinﬂammatory
response to cardiopulmonary bypass—part 1-mechanisms
of pathogenesis,” Journal of Cardiothoracic and Vascular
Anesthesia, vol. 23, no. 2, pp. 223–231, 2009.
[49] E. Zupancich, D. Paparella, F. Turani et al., “Mechanical
ventilationaﬀectsinﬂammatorymediatorsinpatientsunder-
going cardiopulmonary bypass for cardiac surgery: a ran-
domizedclinicaltrial,”JournalofThoracicandCardiovascular
Surgery, vol. 130, no. 2, pp. 378–383, 2005.
[50] D. Reis Miranda, D. Gommers, A. Struijs et al., “Ventilation
according to the open lung concept attenuates pulmonary
inﬂammatory response in cardiac surgery,” European Journal
of Cardiothoracic Surgery, vol. 28, no. 6, pp. 889–895, 2005.
[ 5 1 ]O .K o n e r ,S .C e l e b i ,H .B a l c i ,G .C e t i n ,K .K a r a o g l u ,
and N. Cakar, “Eﬀects of protective and conventional
mechanical ventilation on pulmonary function and systemic
cytokine release after cardiopulmonary bypass,” Intensive
Care Medicine, vol. 30, no. 4, pp. 620–626, 2004.
[52] H. Wrigge, U. Uhlig, G. Baumgarten et al., “Mechanical ven-
tilationstrategiesandinﬂammatoryresponsestocardiacsur-
gery: a prospective randomized clinical trial,” Intensive Care
Medicine, vol. 31, no. 10, pp. 1379–1387, 2005.
[53] S. Sundar, V. Novack, K. Jervis et al., “Inﬂuence of low tidal
volume ventilation on time to extubation in cardiac surgical
patients,”Anesthesiology,vol.114,no.5,pp.1102–1110,2011.
[54] F. Lellouche, S. Dionne, S. Simard, J. Bussi` eres, and F.
Dagenais, “Traditional and high tidal volumes are associated
with prolonged mechanical ventilation and organ failure
after cardiac surgery,” Anesthesiology. In press.
[55] H. Wrigge, J. Zinserling, F. Stuber et al., “Eﬀects of
mechanical ventilation on release of cytokines into systemic
circulation in patients with normal pulmonary function,”
Anesthesiology, vol. 93, no. 6, pp. 1413–1417, 2000.
[56] G. Choi, E. K. Wolthuis, P. Bresser et al., “Mechanical ven-
tilation with lower tidal volumes and positive end-expiratory
pressure prevents alveolar coagulation in patients without
lung injury,” Anesthesiology, vol. 105, no. 4, pp. 689–695,
2006.
[57] A. Zanella, G. Bellani, and A. Pesenti, “Airway pressure and
ﬂow monitoring,” Current Opinion in Critical Care, vol. 16,
no. 3, pp. 255–260, 2010.
[58] T. S. Leary, Q. J. W. Milner, and D. J. Niblett, “The accuracy
of the estimation of body weight and height in the intensive
care unit,” European Journal of Anaesthesiology, vol. 17, no.
11, pp. 698–703, 2000.
[59] J. C. Richard, S. M. Maggiore, B. Jonson, J. Mancebo, F.
Lemaire,andL.Brochard,“Inﬂuenceoftidalvolumeonalve-
olar recruitment: respective role of PEEP and a recruitment
maneuver,” American Journal of Respiratory and Critical Care
Medicine, vol. 163, no. 7, pp. 1609–1613, 2001.
[60] R. D´ ery, J. Pelletter, A. Jacques, M. Clavet, and J. Houde,
“Alveolar collapse induced by denitrogenation,” Canadian
Anaesthetists’ Society Journal, vol. 12, no. 6, pp. 531–544,
1965.
[61] J. Aboab, B. Jonson, A. Kouatchet, S. Taille, L. Niklason, and
L. Brochard, “Eﬀect of inspired oxygen fraction on alveolar
derecruitment in acute respiratory distress syndrome,” Inten-
sive Care Medicine, vol. 32, no. 12, pp. 1979–1986, 2006.
[62] G. Hedenstierna and L. Edmark, “Mechanisms of atelectasis
in the perioperative period,” Best Practice and Research, vol.
24, no. 2, pp. 157–169, 2010.
[63] A. Jubran, “Pulse oximetry,” Intensive Care Medicine, vol. 30,
no. 11, pp. 2017–2020, 2004.
[64] F. Manzano, E. Fern´ andez-Mond´ ejar, M. Colmenero et
al., “Positive-end expiratory pressure reduces incidence of
ventilator-associated pneumonia in nonhypoxemic patients,”
Critical Care Medicine, vol. 36, no. 8, pp. 2225–2231, 2008.
[65] P. G. H. Metnitz, B. Metnitz, R. P. Moreno et al., “Epi-
demiology of mechanical ventilation: analysis of the SAPS 3
database,” Intensive Care Medicine, vol. 35, no. 5, pp. 816–
824, 2009.
[66] D. Talmor, T. Sarge, A. Malhotra et al., “Mechanical ventila-
tionguidedbyesophagealpressureinacutelunginjury,” New
England Journal of Medicine, vol. 359, no. 20, pp. 2095–2104,
2008.
[67] D. O’Croinin, M. Ni Chonghaile, B. Higgins, and J. G. Laﬀey,
“Bench-to-bedside review: permissive hypercapnia,” Critical
Care, vol. 9, no. 1, pp. 51–59, 2005.
[68] F. Lellouche, S. Taill´ e, F. Lefranc ¸ois et al., “Humidiﬁcation
performance of 48 passive airway humidiﬁers comparison
with manufacturer data,” Chest, vol. 135, no. 2, pp. 276–286,
2009.
[69] S. Prin, K. Chergui, R. Augarde, B. Page, F. Jardin, and A.
Vieillard-Baron, “Ability and safety of a heated humidiﬁer to
control hypercapnic acidosis in severe ARDS,” Intensive Care
Medicine, vol. 28, no. 12, pp. 1756–1760, 2002.
[70] G. Prat, A. Renault, J. M. Tonnelier et al., “Inﬂuence of the
humidiﬁcation device during acute respiratory distress syn-
drome,” Intensive Care Medicine, vol. 29, no. 12, pp. 2211–
2215, 2003.
[71] R. S. Campbell, K. Davis, J. A. Johannigman, and R. D.
Branson, “The eﬀects of passive humidiﬁer dead space on
respiratory variables in paralyzed and spontaneously breath-
ing patients,” Respiratory Care, vol. 45, no. 3, pp. 306–312,
2000.
[72] I. Mor´ an, J. Bellapart, A. Vari, and J. Mancebo, “Heat and
moisture exchangers and heated humidiﬁers in acute lung
injury/acute respiratory distress syndrome patients. Eﬀects
on respiratory mechanics and gas exchange,” Intensive Care
Medicine, vol. 32, no. 4, pp. 524–531, 2006.
[73] C. R. Hinkson, M. S. Benson, L. M. Stephens, and S. Deem,
“The eﬀects of apparatus dead space on PaCO2 in patientsCritical Care Research and Practice 11
receiving lung-protective ventilation,” Respiratory Care, vol.
51, no. 10, pp. 1140–1144, 2006.
[74] J. Richecoeur, Q. Lu, S. R. Vieira et al., “Expiratory washout
versus optimization of mechanical ventilation during per-
missive hypercapnia in patients with severe acute respiratory
distress syndrome,” American Journal of Respiratory and
Critical Care Medicine, vol. 160, no. 1, pp. 77–85, 1999.
[75] D. C. Scales and N. K. J. Adhikari, “Lost in (knowledge)
translation: “all breakthrough, no follow through”?” Critical
Care Medicine, vol. 36, no. 5, pp. 1654–1655, 2008.
[76] K. J. Deans, P. C. Minneci, X. Cui, S. M. Banks, C. Natanson,
and P. Q. Eichacker, “Mechanical ventilation in ARDS: one
size does not ﬁt all,” Critical Care Medicine, vol. 33, no. 5, pp.
1141–1143, 2005.
[77] L. Gattinoni, “Counterpoint: is low tidal volume mechanical
ventilation preferred for all patients on ventilation? No,”
Chest, vol. 140, no. 1, pp. 11–13, 2011.
[78] R. D. Hubmayr and L. Gattinoni, “Point: is low tidal volume
mechanical ventilation preferred for all patients on ventila-
tion? Yes,” Chest, vol. 140, no. 1, pp. 9–15, 2011.
[79] P. D. MacNaughton and T. W. Evans, “Measurement of lung
volume and DL(CO) in acute respiratory failure,” American
JournalofRespiratoryandCriticalCareMedicine,vol.150,no.
3, pp. 770–775, 1994.
[ 8 0 ]C .R y l a n d e r ,U .T y l ´ en, R. Rossi-Norrlund, P. Herrmann, M.
Quintel, and B. Bake, “Uneven distribution of ventilation in
acute respiratory distress syndrome,” Critical Care, vol. 9, no.
2, pp. R165–R171, 2005.
[81] D. Chiumello, E. Carlesso, P. Cadringher et al., “Lung stress
and strain during mechanical ventilation for acute respira-
tory distress syndrome,” American Journal of Respiratory and
Critical Care Medicine, vol. 178, no. 4, pp. 346–355, 2008.
[82] L. Gattinoni, E. Carlesso, and P. Caironi, “Stress and strain
within the lung,” Current Opinion in Critical Care, vol. 18,
no. 1, pp. 42–47, 2012.
[83] N. D. Ferguson, F. Frutos-Vivar, A. Esteban et al., “Acute res-
piratory distress syndrome: underrecognition by clinicians
and diagnostic accuracy of three clinical deﬁnitions,” Critical
Care Medicine, vol. 33, no. 10, pp. 2228–2234, 2005.
[84] A. J. Walkey and R. S. Wiener, “Risk factors for underuse of
lung-protective ventilation in acute lung injury,” Journal of
Critical Care. In press.
[85] B. P. Krieger, “Hyperinﬂation and intrinsic positive end-
expiratory pressure: less room to breathe,” Respiration, vol.
77, no. 3, pp. 344–350, 2009.
[86] J. C. Richard, L. Brochard, L. Breton et al., “Inﬂuence of
respiratory rate on gas trapping during low volume ventila-
tion of patients with acute lung injury,” I n t e n s i v eC a r eM e d i -
cine, vol. 28, no. 8, pp. 1078–1083, 2002.
[87] L. Brochard, “Intrinsic (or auto-) PEEP during controlled
mechanical ventilation,” Intensive Care Medicine, vol. 28, no.
10, pp. 1376–1378, 2002.
[88] L. Blanch, F. Bernab´ e, and U. Lucangelo, “Measurement of
air trapping, intrinsic positive end-expiratory pressure, and
dynamic hyperinﬂation in mechanically ventilated patient,”
Respiratory Care, vol. 50, no. 1, pp. 123–124, 2005.
[89] M. Unroe and N. MacIntyre, “Evolving approaches to assess-
ing and monitoring patient-ventilator interactions,” Current
Opinion in Critical Care, vol. 16, no. 3, pp. 261–268, 2010.
[90] M. Schmidt, A. Demoule, A. Polito et al., “Dyspnea in mech-
anically ventilated critically ill patients,” Critical Care Medi-
cine, vol. 39, no. 9, pp. 2059–2065, 2011.
[ 9 1 ]R .H .K a l l e t ,A .R .C a m p b e l l ,R .A .D i c k e r ,J .A .K a t z ,a n dR .
C. Mackersie, “Eﬀects of tidal volume on work of breathing
duringlung-protectiveventilationinpatientswithacutelung
injury and acute respiratory distress syndrome,” Critical Care
Medicine, vol. 34, no. 1, pp. 8–14, 2006.
[92] D. R. Hess and B. T. Thompson, “Patient-ventilator dyssyn-
chrony during lung protective ventilation: what’s a clinician
to do?” Critical Care Medicine, vol. 34, no. 1, pp. 231–233,
2006.
[93] J. O. Nilsestuen and K. D. Hargett, “Using ventilator graphics
to identify patient-ventilator asynchrony,” Respiratory Care,
vol. 50, no. 2, pp. 202–232, 2005.
[94] J. M. Kahn, L. Andersson, V. Karir, N. L. Polissar, M. J. Neﬀ,
and G. D. Rubenfeld, “Low tidal volume ventilation does
not increase sedation use in patients with acute lung injury,”
Critical Care Medicine, vol. 33, no. 4, pp. 766–771, 2005.
[95] L. Papazian, J.-M. Forel, A. Gacouin et al., “Neuromuscular
blockers in early acute respiratory distress syndrome,” New
England Journal of Medicine, vol. 363, no. 12, pp. 1107–1116,
2010.
[96] G. D. Rubenfeld, C. Cooper, G. Carter, B. T. Thompson, and
L. D. Hudson, “Barriers to providing lung-protective ven-
tilation to patients with acute lung injury,” Critical Care
Medicine, vol. 32, no. 6, pp. 1289–1293, 2004.
[97] H. Fuchs, M. R. Mendler, D. Scharnbeck, M Ebsen, and
H. D. Hummler, “Very low tidal volume ventilation with
associatedhypercapnia—eﬀectsonlunginjuryinamodelfor
acuterespiratorydistresssyndrome,” PLoSONE,vol.6,no.8,
article e23816, 2011.
[98] A. E. de Graaﬀ, D. A. Dongelmans, J. M. Binnekade, and
E. de Jonge, “Clinicians’ response to hyperoxia in ventilated
patients in a Dutch ICU depends on the level of FiO2,”
Intensive Care Medicine, vol. 37, no. 1, pp. 46–51, 2011.
[99] W.A.AltemeierandS.E.Sinclair,“Hyperoxiaintheintensive
care unit: why more is not always better,” Current Opinion in
Critical Care, vol. 13, no. 1, pp. 73–78, 2007.
[100] T. F. Floyd, J. M. Clark, R. Gelfand et al., “Independent cere-
bral vasoconstrictive eﬀects of hyperoxia and accompanying
arterial hypocapnia at 1 ATA,” Journal of Applied Physiology,
vol. 95, no. 6, pp. 2453–2461, 2003.
[101] H.Farquhar,M.Weatherall,M.Wijesingheetal.,“Systematic
review of studies of the eﬀecto fh ype r o x i ao nc o r o n a ryb l ood
ﬂow,” American Heart Journal, vol. 158, no. 3, pp. 371–377,
2009.
[102] M. Wijesinghe, K. Perrin, A. Ranchord, M. Simmonds,
M. Weatherall, and R. Beasley, “Routine use of oxygen in
the treatment of myocardial infarction: systematic review,”
Heart, vol. 95, no. 3, pp. 198–202, 2009.
[103] I. D. Graham, J. Logan, M. B. Harrison et al., “Lost in knowl-
edge translation: time for a map?” Journal of Continuing
Education in the Health Professions, vol. 26, no. 1, pp. 13–24,
2006.
[104] C. R. Weinert, C. R. Gross, and W. A. Marinelli, “Impact of
randomized trial results on acute lung injury ventilator ther-
apy in teaching hospitals,” American Journal of Respiratory
and Critical Care Medicine, vol. 167, no. 10, pp. 1304–1309,
2003.
[105] M. P. Young, H. L. Manning, D. L. Wilson et al., “Ventilation
of patients with acute lung injury and acute respiratory dis-
tress syndrome: has new evidence changed clinical practice?”
Critical Care Medicine, vol. 32, no. 6, pp. 1260–1265, 2004.
[106] N. J. Umoh, E. Fan, P. A. Mendez-Tellez et al., “Patient and
intensive care unit organizational factors associated with low
tidal volume ventilation in acute lung injury,” Critical Care
Medicine, vol. 36, no. 5, pp. 1463–1468, 2008.
[107] W. Checkley, R. Brower, A. Korpak, and B. T. Thompson,
“Eﬀects of a clinical trial on mechanical ventilation practices12 Critical Care Research and Practice
in patients with acute lung injury,” American Journal of Res-
piratory and Critical Care Medicine, vol. 177, no. 11, pp.
1215–1222, 2008.
[108] A. Esteban, N. D. Ferguson, M. O. Meade et al., “Evolution
of mechanical ventilation in response to clinical research,”
American Journal of Respiratory and Critical Care Medicine,
vol. 177, no. 2, pp. 170–177, 2008.
[109] R. Bloomﬁeld, E. Steel, G. MacLennan, and D. W. Noble,
“Accuracy of weight and height estimation in an intensive
care unit: implications for clinical practice and research,”
Critical Care Medicine, vol. 34, no. 8, pp. 2153–2157, 2006.
[110] K. M. Hendershot, L. Robinson, J. Roland, K. Vaziri, A. G.
Rizzo,andS.M.Fakhry,“Estimatedheight,weight,andbody
mass index: implications for research and patient safety,”
Journal of the American College of Surgeons, vol. 203, no. 6,
pp. 887–893, 2006.
[111] L. P. Maskin, S. Attie, M. Setten et al., “Accuracy of weight
and height estimation in an intensive care unit,” Anaesthesia
and Intensive Care, vol. 38, no. 5, pp. 930–934, 2010.
[112] S. Han, G. S. Martin, J. P. Maloney et al., “Short women with
severe sepsis-related acute lung injury receive lung protective
ventilation less frequently: an observational cohort study,”
Critical Care, vol. 15, no. 6, article R262, 2011.
[113] iAnthropometerICU1,2011,http://itunes.apple.com/ca/app/
ianthropometer-icu-1/id428778012?mt=8.
[114] A. Bojmehrani, C. Bouchard, P. A. Bouchard, E. L’Her, and
F. Lellouche, “Evaluation of new tool to measure patient’s
height during mechanical ventilation: impact on protective
ventilation (freesize),” Respiratory Care Open Forum, 2011.
[115] F. Lellouche, P. A. Bouchard, M. Wysocki et al., “Prospec-
tive randomized controlled study comparing conventional
ventilation versus a fully closed-loop ventilation (IntelliVent)
in post cardiac surgery ICU patients,” American Journal
of Respiratory and Critical Care Medicine, vol. 181, article
A6035, 2010.
[116] G.A.Iotti,A.Polito,M.Belliatoetal.,“Adaptivesupportven-
tilation versus conventional ventilation for total ventilatory
support in acute respiratory failure,” Intensive Care Medicine,
vol. 36, no. 8, pp. 1371–1379, 2010.
[117] P. C. Gruber, C. D. Gomersall, P. Leung et al., “Randomized
controlled trial comparing adaptive-support ventilation with
pressure-regulated volume-controlled ventilation with auto-
mode in weaning patients after cardiac surgery,” Anesthesiol-
ogy, vol. 109, no. 1, pp. 81–87, 2008.
[118] K. E. A. Burns, F. Lellouche, and M. R. Lessard, “Automating
the weaning process with advanced closed-loop systems,”
Intensive Care Medicine, vol. 34, no. 10, pp. 1757–1765, 2008.
[119] R. D. Branson and K. Davis, “Does closed loop control
of assist control ventilation reduce ventilator-induced lung
injury?” Clinics in Chest Medicine, vol. 29, no. 2, pp. 343–350,
2008.
[120] M. J. Schultz, J. J. Haitsma, A. S. Slutsky, and O. Gajic, “What
tidal volumes should be used in patients without acute lung
injury?” Anesthesiology, vol. 106, no. 6, pp. 1226–1231, 2007.